John Cafardi

460 total citations
19 papers, 352 citations indexed

About

John Cafardi is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, John Cafardi has authored 19 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Hepatology. Recurrent topics in John Cafardi's work include Hepatitis C virus research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). John Cafardi is often cited by papers focused on Hepatitis C virus research (5 papers), COVID-19 Clinical Research Studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). John Cafardi collaborates with scholars based in United States, Israel and Vietnam. John Cafardi's co-authors include Tatyana Kushner, Jeffrey C. Edberg, Andrew Gibson, Kaihong Su, Robert P. Kimberly, Xiaoli Li, Xinrui Li, Hengxuan Yang, Tong Zhou and Judith Feinberg and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Hepatology.

In The Last Decade

John Cafardi

18 papers receiving 343 citations

Peers

John Cafardi

IMMUN

EPIDE

RNMI

RHEUM

Parichart Permpikul Thailand

Chia-Wei Hsieh Taiwan

Nele Esters Belgium

B G Feagan Canada

Natalie Stieltjes France

J Verwilghen Belgium

Kristján Erlendsson Iceland

Astrid Rascu Germany

S Katz United States

D F Woodrow United Kingdom

Parichart Permpikul Thailand

John Cafardi

47 ×0.3

IMMUN

79 ×0.6

EPIDE

50 ×0.4

RNMI

83 ×1.0

123 ×2.3

RHEUM

Citations per year, relative to John Cafardi John Cafardi (= 1×) peers Parichart Permpikul

Countries citing papers authored by John Cafardi

Since Specialization

Citations

This map shows the geographic impact of John Cafardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Cafardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Cafardi more than expected).

Fields of papers citing papers by John Cafardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Cafardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Cafardi. The network helps show where John Cafardi may publish in the future.

Co-authorship network of co-authors of John Cafardi

This figure shows the co-authorship network connecting the top 25 collaborators of John Cafardi. A scholar is included among the top collaborators of John Cafardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Cafardi. John Cafardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Roskin, Krishna M., Matthew Juhascik, John Cafardi, et al.. (2025). Single cell RNA transcriptome response to fentanyl use in persons with hepatitis C virus infection. Frontiers in Virology. 5.

Cafardi, John, et al.. (2024). Vertical Transmission of Hepatitis C Virus Among Women With a History of Injection Opioid Use. Clinical Infectious Diseases. 79(3). 701–704. 1 indexed citations

Cafardi, John, et al.. (2023). A Review of Heart Failure in Patients with COVID-19. Heart Failure Clinics. 19(2). e1–e8. 4 indexed citations

Shebley, Mohamad, Stanley Wang, Preethi Krishnan, et al.. (2022). Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS‐CoV‐2 neutralizing monoclonal antibody ABBV‐47D11 in patients with COVID‐19. Pharmacology Research & Perspectives. 11(1). e01036–e01036. 6 indexed citations

Cafardi, John, Carole B. Miller, Howard R. Terebelo, et al.. (2022). Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19. JAMA Network Open. 5(12). e2242918–e2242918. 5 indexed citations

Cafardi, John, et al.. (2021). Opportunistic Fungal Infection Associated With COVID-19. Open Forum Infectious Diseases. 8(7). ofab016–ofab016. 34 indexed citations

Kushner, Tatyana & John Cafardi. (2020). Chronic Liver Disease and COVID‐19: Alcohol Use Disorder/Alcohol‐Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis. Clinical Liver Disease. 15(5). 195–199. 36 indexed citations

Cafardi, John, et al.. (2020). Brucella Endocarditis in Persons Who Inject Drugs. Open Forum Infectious Diseases. 7(4). ofaa063–ofaa063. 2 indexed citations

Kushner, Tatyana, John Cafardi, & Nancy Reau. (2019). Considering direct-acting antivirals to cure hepatitis C virus during pregnancy: is this the last treatment frontier?. Therapeutic Advances in Infectious Disease. 6. 4064032277–4064032277. 6 indexed citations

10.

Cuffy, Madison C., Tiffany E. Kaiser, John Cafardi, et al.. (2019). Use of HCV Ab+/NAT− donors in HCV naïve renal transplant recipients to expand the kidney donor pool. Clinical Transplantation. 33(7). e13598–e13598. 18 indexed citations

11.

Cafardi, John, et al.. (2019). HCV in Women and Pregnancy. Hepatology. 70(5). 1836–1840. 6 indexed citations

12.

Truong, Vien T., Hoang C.B. Nguyen, Wojciech Mazur, et al.. (2017). Microbiological profile and risk factors for in-hospital mortality of infective endocarditis in tertiary care hospitals of south Vietnam. PLoS ONE. 12(12). e0189421–e0189421. 16 indexed citations

13.

Cafardi, John, et al.. (2015). Intravenous Immune Globulin in Amyopathic Dermatomyositis - Reportof Two Cases and Review of the Literature. The Open Rheumatology Journal. 9(1). 77–81. 8 indexed citations

14.

Cafardi, John, et al.. (2014). Human Immunodeficiency Virus–Associated Pulmonary Arterial Hypertension Diagnosed Postpartum. Obstetrics and Gynecology. 125(1). 193–195. 1 indexed citations

15.

Cafardi, John, et al.. (2014). Intravenous Immunoglobulin as Salvage Therapy in Refractory Pyoderma Gangrenosum: Report of a Case and Review of the Literature. Case Reports in Dermatology. 6(3). 239–244. 18 indexed citations

16.

Patel, Rajiv M., et al.. (2011). Tumor necrosis factor biologics beyond psoriasis in dermatology. Expert Opinion on Biological Therapy. 11(10). 1341–1359. 14 indexed citations

17.

Gibson, Andrew, Fu Jun Li, Jianming Wu, et al.. (2009). The FCRL3 −169CT promoter single‐nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19+ B cells. Arthritis & Rheumatism. 60(11). 3510–3512. 24 indexed citations

18.

Su, Kaihong, Hengxuan Yang, Xinrui Li, et al.. (2007). Expression Profile of FcγRIIb on Leukocytes and Its Dysregulation in Systemic Lupus Erythematosus. The Journal of Immunology. 178(5). 3272–3280. 152 indexed citations

19.

Cafardi, John, Graciela S. Alarcón, & Kenneth G. Saag. (2007). Effect of reproductive factors on rheumatoid arthritis. 2(2). 177–183. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact